Jefferies Financial Group Lowers Enhabit (NYSE:EHAB) to Hold

Enhabit (NYSE:EHABGet Free Report) was downgraded by equities researchers at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research note issued on Thursday, FinViz reports. They currently have a $8.75 price target on the stock, down from their previous price target of $14.00. Jefferies Financial Group’s target price would indicate a potential downside of 9.70% from the stock’s current price.

EHAB has been the subject of a number of other research reports. Oppenheimer restated a “market perform” rating on shares of Enhabit in a research report on Thursday, March 7th. UBS Group upgraded shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective for the company in a research report on Thursday, March 7th. Two investment analysts have rated the stock with a sell rating and five have issued a hold rating to the stock. Based on data from MarketBeat.com, Enhabit presently has a consensus rating of “Hold” and a consensus price target of $11.21.

View Our Latest Stock Analysis on EHAB

Enhabit Stock Down 2.1 %

Shares of NYSE:EHAB opened at $9.69 on Thursday. The firm has a 50 day simple moving average of $10.39 and a 200-day simple moving average of $10.03. Enhabit has a twelve month low of $7.12 and a twelve month high of $14.59. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $486.05 million, a PE ratio of -5.98, a P/E/G ratio of 1.56 and a beta of 1.98.

Enhabit (NYSE:EHABGet Free Report) last issued its quarterly earnings data on Wednesday, March 6th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.01. Enhabit had a positive return on equity of 1.55% and a negative net margin of 7.69%. The company had revenue of $260.60 million during the quarter, compared to analysts’ expectations of $260.30 million. During the same quarter in the previous year, the business earned $0.32 earnings per share. On average, equities analysts predict that Enhabit will post 0.24 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in EHAB. JANA Partners Management LP acquired a new position in shares of Enhabit during the 3rd quarter valued at $20,532,000. UBS Group AG boosted its position in shares of Enhabit by 7,973.5% in the third quarter. UBS Group AG now owns 1,633,751 shares of the company’s stock worth $18,380,000 after buying an additional 1,613,515 shares during the period. Ancora Advisors LLC grew its stake in shares of Enhabit by 414.5% in the third quarter. Ancora Advisors LLC now owns 1,705,788 shares of the company’s stock valued at $19,190,000 after buying an additional 1,374,231 shares in the last quarter. DekaBank Deutsche Girozentrale raised its holdings in shares of Enhabit by 12,146.2% during the 4th quarter. DekaBank Deutsche Girozentrale now owns 244,924 shares of the company’s stock valued at $2,543,000 after buying an additional 242,924 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Enhabit by 25.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 966,515 shares of the company’s stock worth $10,003,000 after acquiring an additional 193,675 shares in the last quarter.

Enhabit Company Profile

(Get Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Featured Articles

Analyst Recommendations for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.